Does Netupitant And Palonosetron Interact with Warfarin?
Netupitant And Palonosetron and Warfarin have a moderate drug interaction according to U.S. FDA drug labeling data. Monitor INR and adjust warfarin dosage as needed with concomitant use of AKYNZEO to maintain target INR range. The mechanism involves potential increase in s-warfarin exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Netupitant And Palonosetron Class
- Serotonin-3 Receptor Antagonist
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Netupitant And Palonosetron and Warfarin occurs because potential increase in s-warfarin exposure. Clinically, this means monitor inr and adjust warfarin dosage as needed with concomitant use of akynzeo to maintain target inr range. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Netupitant And Palonosetron and your doctor is considering prescribing Warfarin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider